Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
42
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 47 publications
(45 citation statements)
references
References 51 publications
0
42
0
3
Order By: Relevance
“…In some patients, by the end of the first week, the disease can have progression to pneumonia, respiratory failure, and death due to an extreme rise in inflammatory cytokines including IL-2, IL-7, IL-10, GCSF, IP10, MCP1, MIP1A, and TNF-α (Dong et al 2020;Mehta et al 2020, Ruan et al 2020Saghazadeh and Rezaei 2020;Yazdanpanah et al 2020;Zhou et al 2020a). Reported complications are lung impairment including severe respiratory failure and ARDS (Hussain et al 2020;Huang et al 2020;Robba et al 2020), shock (Alhazzani et al 2020;Li et al 2020b;Kamali Aghdam et al 2020), liver and kidney injury (Anders et al, 2020;Naicker et al, 2020;ten Cate 2020;Xu et al 2020), cardiac involvement (Chen et al 2020a;Shi et al, 2020;Liu et al, 2020), thromboembolic complications and coagulopathies (Matteo et al 2020;Orsi et al 2020;Simona et al 2020;Yang et al 2020), neurological manifestations, including acute transverse myelitis, acute encephalitis (Helms et al 2020;Jahanshahlu and Rezaei, 2020;Mao et al 2020;Saleki et al 2020), epileptic seizures, the Guillain-Barré syndrome (Carod-Artal 2020; Nalleballe et al 2020), neurological damage associated with mentioned coagulopathy, systemic and local thrombotic events which occur during this infection (Huang et al 2020) and ischemic or hemorrhagic stroke (Ashrafi et al 2020;Avula et al 2020;Oxley et al 2020). In this review, we discuss stroke as a presentation of COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…In some patients, by the end of the first week, the disease can have progression to pneumonia, respiratory failure, and death due to an extreme rise in inflammatory cytokines including IL-2, IL-7, IL-10, GCSF, IP10, MCP1, MIP1A, and TNF-α (Dong et al 2020;Mehta et al 2020, Ruan et al 2020Saghazadeh and Rezaei 2020;Yazdanpanah et al 2020;Zhou et al 2020a). Reported complications are lung impairment including severe respiratory failure and ARDS (Hussain et al 2020;Huang et al 2020;Robba et al 2020), shock (Alhazzani et al 2020;Li et al 2020b;Kamali Aghdam et al 2020), liver and kidney injury (Anders et al, 2020;Naicker et al, 2020;ten Cate 2020;Xu et al 2020), cardiac involvement (Chen et al 2020a;Shi et al, 2020;Liu et al, 2020), thromboembolic complications and coagulopathies (Matteo et al 2020;Orsi et al 2020;Simona et al 2020;Yang et al 2020), neurological manifestations, including acute transverse myelitis, acute encephalitis (Helms et al 2020;Jahanshahlu and Rezaei, 2020;Mao et al 2020;Saleki et al 2020), epileptic seizures, the Guillain-Barré syndrome (Carod-Artal 2020; Nalleballe et al 2020), neurological damage associated with mentioned coagulopathy, systemic and local thrombotic events which occur during this infection (Huang et al 2020) and ischemic or hemorrhagic stroke (Ashrafi et al 2020;Avula et al 2020;Oxley et al 2020). In this review, we discuss stroke as a presentation of COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…There is a tendency to suggest that prophylaxis should be maintained after hospital discharge, because of the hypercoagulable state triggered by the disease. 50,[60][61][62] There is a risk of bleeding in anticoagulant patients, particularly so as the disease worsens. The profile of DIVC in COVID-19 is initially thrombotic, but it can progress to hemorrhagic as the disease progresses.…”
Section: Treatmentmentioning
confidence: 99%
“…Although there are recommendations for COVID-19 management regarding respiratory support, anti-inflammatory treatment, and antiviral therapy, guidelines regarding thrombotic risk assessment and anticoagulation management of hospitalized children with COVID-19 remain absent ( 23 , 24 ). Additionally, the reported antithrombotic prophylaxis regimens are specific to each tertiary hospital, and are largely based on current adult guidelines ( 25 - 27 ).…”
Section: Hemostatic Changes Associated With Covid-19mentioning
confidence: 99%
“…anticoagulation management of hospitalized children with COVID-19 remain absent (23,24). Additionally, the reported antithrombotic prophylaxis regimens are specific to each tertiary hospital, and are largely based on current adult guidelines (25)(26)(27).…”
mentioning
confidence: 99%